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Jimmy Adediran,a Mary P. Leatham-Jensen,a Matthew E. Mokszycki,a Jakob Frimodt-Møller,b Karen A. Krogfelt,b
Krystyna Kazmierczak,c,d,e* Linda J. Kenney,c,d,e Tyrrell Conway,f Paul S. Cohena
Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island, USAa; Department of Microbiological Surveillance and Research, Statens
Serum Institut, Copenhagen, Denmarkb; Jesse Brown Veterans Administration Medical Center, Chicago, Illinois, USAc; Department of Microbiology, University of Illinois—
Chicago, Chicago, Illinois, USAd; Mechanobiology Institute, National University of Singapore, Singapore, Singaporee; Department of Microbiology and Plant Biology,
University of Oklahoma, Norman, Oklahoma, USAf
Previously we reported that the streptomycin-treated mouse intestine selected for two different Escherichia coli MG1655 mu-
tants with improved colonizing ability: nonmotile E. coli MG1655 flhDC deletion mutants that grew 15% faster in vitro in mouse
cecal mucus and motile E. coli MG1655 envZ missense mutants that grew slower in vitro in mouse cecal mucus yet were able to
cocolonize with the faster-growing flhDCmutants. The E. coliMG1655 envZ gene encodes a histidine kinase that is a member of
the envZ-ompR two-component signal transduction system, which regulates outer membrane protein profiles. In the present
investigation, the envZP41L gene was transferred from the intestinally selected E. coli MG1655 mutant to E. coli Nissle 1917, a
human probiotic strain used to treat gastrointestinal infections. Both the E. coli MG1655 and E. coli Nissle 1917 strains contain-
ing envZP41L produced more phosphorylated OmpR than their parents. The E. coliNissle 1917 strain containing envZP41L also
becamemore resistant to bile salts and colicin V and grew 50% slower in vitro in mucus and 15% to 30% slower on several sug-
ars present in mucus, yet it was a 10-fold better colonizer than E. coli Nissle 1917. However, E. coli Nissle 1917 envZP41L was not
better at preventing colonization by enterohemorrhagic E. coli EDL933. The data can be explained according to our “restaurant”
hypothesis for commensal E. coli strains, i.e., that they colonize the intestine as sessile members of mixed biofilms, obtaining the
sugars they need for growth locally, but compete for sugars with invading E. coli pathogens planktonically.
Previously we reported that when streptomycin-treated miceare fed wild-type Escherichia coliMG1655, the intestine selects
for nonmotile flhDC deletion mutants (1, 2) and envZ missense
mutants (3), both of which are better colonizers than the wild
type. The flhDCmutants have deletions of various sizes, beginning
downstream of an IS1 element in the flhDC regulatory region and
extending into or beyond the flhDC structural genes (1, 2). FlhD
and FlhC form the FlhD4C2 complex (4), which activates tran-
scription of class II flagellar genes that encode components of the
flagellar basal body and export machinery (5). The IS1 element
immediately upstream of the E. coli MG1655 flhDC promoter in-
creases expression of the flhDC operon andmakes E. coliMG1655
hypermotile (1, 6). One of the better-colonizing nonmotile flhDC
deletion mutants, E. coli MG1655 flhD, grew 15% faster in vitro
in mouse cecal mucus and 15% to 30% faster on several sugars
present in cecal mucus than E. coli MG1655 (1), presumably ex-
plaining its better colonizing ability. Additional studies suggested
that the E. coli MG1655 flhDC operon deletion mutants utilize
sugars better than their parent at least in part because a number of
metabolic genes are repressed by the FlhD4C2 regulatory complex,
including gltA (citrate synthase), sdhCDAB (succinate dehydroge-
nase), mdh (malate dehydrogenase), mglBAC (galactose trans-
port), and a large number of sugar catabolism operons (7–9).
EnvZ, a histidine kinase, and OmpR, its cognate response reg-
ulator, comprise a two-component signal transduction system
that modulates gene expression in response to osmolarity (10).
Among the many activities controlled by EnvZ-OmpR are tran-
scription of ompF, which encodes anE. coli outermembrane porin
that allows passage of bile salts as well as other small molecules
from the environment into the periplasm (11); transcription of
the flhDC operon (12); and transcription of omrA and omrB,
which encode two small RNAs that regulate the expression of a
number of outermembrane proteins, includingCirA, the receptor
for colicin V (13). The better-colonizing E. coli MG1655 envZ
missense mutants were more resistant to bile salts and colicin V
than E. coli MG1655 and E. coli MG1655 flhD and were less
motile than E. coli MG1655, consistent with them containing a
higher level of phosphorylated OmpR (OmpRP) (3). One bet-
ter-colonizing E. coli MG1655 envZ missense mutant which was
studied further, i.e., E. coli MG1655 mot-1 (referred to here as E.
coli MG1655 envZP41L), grew about 15% slower in mouse cecal
mucus in vitro and on several sugars present in mucus than E. coli
MG1655 flhD, but it grew 30% faster on galactose (3). In addi-
tion, despite growing slower in mouse cecal mucus in vitro, E. coli
MG1655 envZP41L appeared to colonize one intestinal niche in the
cecum as well as E. coli MG1655 flhD, suggesting that factors
other than competition for nutrients were responsible, and it ap-
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peared to use galactose to colonize a second intestinal niche in the
cecum that was either not colonized or poorly colonized by E. coli
MG1655 flhD (3).
E. coliNissle 1917 is a commensal strain that has been used as a
probiotic agent to treat gastrointestinal infections in humans since
the early 1920s (14). Several features of E. coli Nissle 1917 have
been proposed to be responsible for its probiotic nature, including
its ability to express two microcins (15), the absence of known
protein toxins, its semirough lipopolysaccharide, and hence se-
rum sensitivity (16, 17), and the presence of six iron uptake sys-
tems (18). To study the envZ derivative encoding the P41L muta-
tion (envZP41L) further, we constructed an envZP41L derivative of
E. coliNissle 1917 and in the present study characterized the strain
and tested whether it has improved mouse intestinal colonizing
ability and whether it is better at limiting colonization of E. coli
EDL933, a human enterohemorrhagic strain. We found that E.
coli Nissle 1917 envZP41L is not a better probiotic, but like E. coli
MG1655 envZP41L, it colonized an intestinal niche not colonized
by wild-type E. coliNissle 1917. We discuss the results in terms of
the restaurant hypothesis.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains used in this study are listed in Table 1.
The original E. coli K-12 strain was obtained from a stool sample from a
convalescing diphtheria patient in Palo Alto, CA, in 1922 (19). The se-
quencedE. coliMG1655 strain (CGSC7740)was derived from the original
K-12 strain, having only been cured of the temperate bacteriophage
lambda and the F plasmid by means of UV light and acridine orange
treatment (19). It has an IS1 element in the flhDC promoter (20). E. coli
Nissle 1917was originally isolated duringWorldWar I from a soldier who
escaped a severe outbreak of diarrhea (14). It has a beneficial effect on
several types of intestinal disorders, is well tolerated by humans, and has
beenmarketed as a probiotic remedy against intestinal disorders in several
European countries since the 1920s (14). The allelic exchange method
described by Datsenko and Wanner (21) was used to construct E. coli
Nissle 1917 Strr envZP41L galK::cat (Table 1), which contains a 912-bp
deletion replaced by a chloramphenicol cassette beginning 153 bp down-
stream of the ATG start codon and ending 78 bp upstream of the TGA
stop codon. As expected, E. coliNissle 1917 Strr envZP41LgalK::cat failed
to grow in M9 minimal medium (22) containing 0.4% (wt/vol) galactose
as the sole carbon and energy source. E. coli Nissle 1917 Strr envZP41L
galK::catwas restored to theGal phenotype by allelic replacement (21),
TABLE 1 Bacterial strains used in this studya
E. coli strain Description Name used in text
Source or
reference
EDL933 Strr Rifr Spontaneous rifampin-resistant mutant of EDL933 Strr EDL933 34
MG1655 Strr Spontaneous streptomycin-resistant mutant of MG1655 MG1655 3
MG1655 Strr Nalr Spontaneous nalidixic acid-resistant mutant of MG1655 Strr MG1655 3
MG1655 Strr mot-1 P41L envZ missense mutant of MG1655 Strr MG1655 envZP41L 3
MG1655 Strr mot-2 P148S envZ missense mutant of MG1655 Strr MG1655 envZP148S 3
MG1655 Strr mot-3 V33E envZ missense mutant of MG1655 Strr MG1655 envZV33E 3
MG1655 Strr Nalr mot-1 Spontaneous nalidixic acid-resistant mutant of MG1655 Strr
mot-1
MG1655 envZP41L 3
MG1655 Strr Nalr mot-1 restored MG1655 Strr mot-1 restored to wild type with respect to EnvZ MG1655 envZP41L restored to
wild type with respect to
EnvZ
3
MG1655 Strr envZNis MG1655 Str
r with the Nissle 1917 envZ gene MG1655 envZNis This study
MG1655 Strr Nalr envZNis Spontaneous nalidixic acid-resistant mutant of MG1655 Str
r
envZNis
MG1655 envZNis This study
Nissle 1917 Strr Spontaneous streptomycin-resistant mutant of Nissle 1917 Nissle 1917 34
Nissle 1917 Strr Nalr Spontaneous nalidixic acid-resistant mutant of Nissle 1917
Strr
Nissle 1917 34
Nissle 1917 Strr envZP41L Nissle 1917 Str
r with the envZP41L gene in place of its own Nissle 1917 envZP41L This study
Nissle 1917 Strr Nalr envZP41L Spontaneous nalidixic acid-resistant mutant of Nissle 1917
Strr envZP41L
Nissle 1917 envZP41L This study
Nissle 1917 Strr envZP41L restored Nissle 1917 Str
r envZP41L restored to wild type with respect to
EnvZ
Nissle 1917 envZP41L restored
to wild type with respect to
EnvZ
This study
Nissle 1917 Strr galK::cat 912-bp deletion in galactokinase gene replaced by a
chloramphenicol resistance cassette
Nissle 1917 galK::cat This study
Nissle 1917 Strr envZP41L
galK::cat
Same deletion as in Nissle 1917 Strr galK::cat Nissle 1917 envZP41L galK::cat This study
Nissle 1917 Strr envZP41L galK::
cat restored
Nissle 1917 Strr envZP41L galK::cat restored to wild type with
respect to galK
Nissle 1917 envZP41L galK::cat
restored to wild type with
respect to galK
This study
Nissle 1917 Strr Nalr envZP41L
galK::cat restored
Spontaneous nalidixic acid-resistant mutant of Nissle 1917
Strr envZP41L galK::cat restored
Nissle 1917 envZP41L galK::cat
restored to wild type with
respect to galK
This study
F-18 Strr Rifr Spontaneous streptomycin- and rifampin-resistant mutant of
F-18
F-18 31
BW37751(pKD267)::Kanr The plasmid in this strain contains parE under the control of
the rhamnose promoter and the kanamycin resistance gene
pKD267 Barry Wanner
a Strr, streptomycin resistant; Rifr, rifampin resistant; Nalr, nalidixic acid resistant; Kanr, kanamycin resistant.
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with selection for restored growth on M9 minimal galactose agar plates.
The restored Gal strain grew at the same rate as E. coli Nissle 1917 Strr
envZP41L in M9 galactose minimal medium. The E. coli MG1655 envZ
gene was replaced with the E. coli Nissle 1917 wild-type envZ gene by an
unpublished allelic replacement strategy developed by BarryWanner and
Kiryl Datsenko at Purdue University, as described previously (3). The
samemethodwas used to replace the E. coliNissle 1917 envZ genewith the
envZP41L gene. All constructions were confirmed by sequencing.
Growth of strains and sample preparation for detection of phos-
phorylated OmpR. Bacteria were grown overnight in the presence of 100
g/ml of streptomycin sulfate in M9 minimal medium (22) supple-
mented with 0.2% glucose orM63medium (23) supplemented with 0.2%
glucose and 0.0005%vitaminB1. Cells were diluted 100- to 200-fold in the
same medium or medium supplemented with 150 mM NaCl or 15%
sucrose, respectively. Cultures (32 to 35 ml) were grown to an optical
density at 600 nm (OD600) of0.5 to 0.7 and harvested by centrifugation
at 14,500  g for 10 min at 4°C. Samples were prepared for Phos-tag
analysis as described byWayne et al. (24), with the following changes. For
samples grown inM63medium, cell pellets were suspended in 1ml of cold
20 mM Tris-HCl, pH 7.0, supplemented with 15% sucrose and EDTA-
free bacterial protease inhibitor cocktail (RPI Corp.,Mount Prospect, IL).
Suspensions were transferred to chilled tubes of lysing matrix B (MP
Biomedicals, Solon, OH), and cells were disrupted by two 40-s cycles of
homogenization at a speed of 6.0 m/s in a FastPrep-24 instrument (MP
Biomedicals). Samples were chilled on ice for 5 min between disruption
cycles. For samples grown inM9medium, cell pellets were suspended in 1
ml of cold BugBuster master mix (Novagen, Darmstadt, Germany) sup-
plemented with EDTA-free bacterial protease inhibitor cocktail (RPI
Corp.). Suspensions were transferred to chilled tubes of lysing matrix B
(MP Biomedicals) and incubated on a platform shaker for 15 min at 4°C.
Cells were disrupted by one 20-s cycle of homogenization at a speed of 4.0
m/s in a FastPrep-24 instrument (MP Biomedicals). After cell disruption,
all samples were centrifuged at 10,000 rpm for 1 min at 4°C, and 75 l of
each cleared lysate was mixed with cold 4 Laemmli buffer (Bio-Rad,
Hercules, CA). Samples were frozen on dry ice and stored at80°C until
analysis.
SDS-PAGE,Western blotting, and detection of OmpR andOmpRP.
SDS-PAGE andWestern blotting were performed as described byWayne
et al. (24), with the following changes. Samples were thawed briefly on ice.
Approximately 16OD600 units of each samplewas loaded into eachwell of
a chilled 10% SDS-polyacrylamide gel containing 25Mor 50MPhos-
tag acrylamide (AAL-107; Wako Chemicals USA Inc., Richmond, VA)
and then separated by electrophoresis at 140 V for 2.25 h at 4°C. Proteins
were transferred to a 0.45-m Immobilon-P membrane (polyvinylidene
difluoride [PVDF]; EMD Millipore, Billerica, MA) at 30 V for 15 h, fol-
lowed by an additional 1 h at 100 V. Membranes were blocked in 3%
(wt/vol) Amersham ECL blocking agent (GE Healthcare Biosciences,
Pittsburgh, PA) in 1 Tris-buffered saline (TBS), 0.5% (vol/vol) Tween
20, incubated in a 1:50 to 1:80 dilution of affinity-purified rabbit anti-
OmpR antibody for 24 h at 4°C, and then incubated in a 1:100,000 dilu-
tion of horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG
(Pierce Antibodies, Rockford, IL) for 1 h at room temperature (RT). Sig-
nals were detected using SuperSignal West Pico chemiluminescent sub-
strate (Pierce Antibodies) followed by exposure to Hyblot-CL film (Den-
ville Scientific Inc., Plainfield, NJ).
Outer membrane protein analysis. Outer membrane fractions were
prepared as described by Morona and Reeves (25), with the following
modifications. Briefly, bacteria were grown overnight in LB broth supple-
mentedwith 100g/ml of streptomycin sulfate. Cells were diluted 100- to
200-fold in medium A (26) and medium A supplemented with 15% su-
crose and grown to an OD600 of0.6 to 1.0. Cultures (25 to 30 ml) were
harvested by centrifugation at 3,000 g for 15 min at 4°C, and cell pellets
were frozen on dry ice. After storage at20°C, pellets were thawed on ice
and suspended in 0.2 ml of 20% (wt/vol) sucrose in 30 mMTris-HCl, pH
8.8. Fifty microliters of lysozyme solution (5 mg/ml) in 5 mM Tris-HCl,
pH 8.0, 0.1 M EDTA, pH 8.0, was added to each suspension. After 30 min
of incubation on ice, 5 ml of cold 3 mM EDTA was added to the suspen-
sions, which weremixed by vortexing and sonicated three times for 30 s at
power setting 7, using a Fisher Scientific model 100 Sonic Dismembrator
instrument. Cellular debris was removed by centrifugation at 3,000  g
for 15 min at 4°C. Supernatants were centrifuged at 21,000 g for 1 h at
4°C, and membrane pellets were suspended in 100 l of 4 Laemmli
buffer. Samples were heated at 95°C for 10 min before electrophoresis at
125 V on 4 M urea, 10% SDS-polyacrylamide gels.
Other media and growth conditions. LB broth Lennox (Difco Labo-
ratories, Detroit, MI), LB agar Lennox (Difco), and MacConkey agar
(Difco) were used for routine cultivation. SOC medium was prepared as
described byDatsenko andWanner (21). For testing of carbon and energy
source utilization,M9minimalmedium (22) wasmodified by addition of
120 mMNaCl to more closely approximate the sodium chloride concen-
tration in the intestine (27).Growthwas also tested in cecalmucus (2.5mg
protein/ml) in HEPES-Hanks buffer (pH 7.0), which contains 137 mM
NaCl, the sodium chloride concentration in jejunal and ileal intestinal
fluid (27). Cultures were prepared and growth was monitored as de-
scribed previously (1).
Isolation of cecal mucus. Mouse cecal mucus was isolated as previ-
ously described (28). Briefly, mice (5 to 8 weeks old) were fed Teklad
mouse and rat diet (Harlan Laboratories, Madison, WI) for 5 days after
being received. The drinking water was then replaced with sterile distilled
water containing streptomycin sulfate (5 g/liter). Twenty-four hours later,
the mice were sacrificed by CO2 asphyxiation, and their ceca were re-
moved. The cecal contents were washed out with sterile distilled water,
and cecal mucus was scraped into HEPES-Hanks buffer (pH 7.0), centri-
fuged, and sterilized by UV irradiation as described previously (28). All
animal protocols were approved by theUniversity Committee onUse and
Care of Animals at the University of Rhode Island.
Motility. Motility of E. coli Nissle 1917 strains was assayed by trans-
ferring colonies by toothpick from LB agar Lennox onto Luria motility
agar as described previously (3). Plates were incubated at 37°C for 6 h,
after which spreading was measured from the edge of each colony.
Growth in the presence of 5% bile salts. Strains to be tested for bile
sensitivity were grown overnight in LB broth Lennox, diluted to anOD600
of about 0.1 in fresh LB broth Lennox containing 5% (wt/vol) Bacto bile
salts no. 3 (Difco Laboratories), and incubated at 37°C with shaking in
125-ml tissue culture bottles. Growth was monitored as described previ-
ously (1).
Mouse colonization experiments. The specifics of the streptomycin-
treated mouse model used to compare the large intestine-colonizing abil-
ities of E. coli strains in mice have been described previously (3). Briefly,
sets of three male CD-1mice (5 to 8 weeks old) were given drinking water
containing streptomycin sulfate (5 g/liter) for 24 h to eliminate resident
facultative bacteria (29). Following 18 h of starvation for food and water,
the mice were fed 1 ml of 20% (wt/vol) sucrose containing 105 CFU or
1010 CFU of LB broth Lennox-grown E. coli strains, as described in Re-
sults. After ingestion of the bacterial suspension, both the food (Teklad
mouse and rat diet; Harlan Laboratories, Madison, WI) and streptomy-
cin-water were returned to the mice, and 1 g of feces was collected after 5
h and 24 h and on odd-numbered days, at the indicated times. Mice were
housed individually in cages without bedding and were placed in clean
cages at 24-h intervals. Individual fecal pellets were therefore no older
than 24 h. Each fecal sample (1 g) was homogenized in 10 ml of 1% Bacto
tryptone (Difco), diluted in the samemedium, and plated onMacConkey
agar plates with appropriate antibiotics.When appropriate, 1 ml of a fecal
homogenate (sampled after the feces had settled) was centrifuged at
12,000 g, resuspended in 100 l of 1% Bacto tryptone, and plated on a
MacConkey agar plate with appropriate antibiotics. This procedure in-
creased the sensitivity of the assay from 102 CFU/g of feces to 10 CFU/per
g of feces. To distinguish the various E. coli strains in feces, dilutions were
plated on lactose MacConkey agar containing streptomycin sulfate (100
g/ml), streptomycin sulfate (100 g/ml) and nalidixic acid (50 g/ml),
Adediran et al.
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streptomycin sulfate (100 g/ml) and chloramphenicol (30 g/ml), or
streptomycin sulfate (100g/ml) and rifampin (50g/ml). Streptomycin
sulfate, chloramphenicol, and nalidixic acid were purchased from Sigma-
Aldrich (St. Louis, MO). All plates were incubated for 18 to 24 h at 37°C
prior to counting. When necessary to distinguish strains, 100 colonies
from plates containing streptomycin were transferred by toothpick onto
MacConkey agar plates containing streptomycin and nalidixic acid or
ontoMacConkey agar plates containing streptomycin and chloramphen-
icol. Each colonization experiment was performed at least twice, with
essentially identical results. Pooled data from at least two independent
experiments (for a total of six mice) are presented in the figures.
Sequencing and primers. DNA sequencing was done at the URI
Genomics and Sequencing Center, University of Rhode Island, Kingston,
RI, using an Applied Biosystems 3130xl genetic analyzer (Applied Biosys-
tems, Foster City, CA). A BigDye Terminator v3.1 cycle sequencing kit
(Applied Biosystems)was used for the sequencing reactions. Primers were
designed using the E. coli K-12 genome sequence (20) or the E. coli
CFT073 genome sequence (30), which is closely related to theE. coliNissle
1917 genome sequence (18).
The galK deletion primers used tomake E. coliNissle 1917 StrrgalK::
cat (uppercase letters, E. coliNissle 1917DNA; lowercase letters, chloram-
phenicol resistance cassette DNA) were as follows: primer 1, 5=-AAACG
TAAAAAGTCTCTTTAATACCTGTTTTTGCTTCATATTGTTCAGC
gtgtaggctggagctgcttcg-3=; and primer 2, 5=-CGACTACAACGAC
GGTTTCGTTCTGCCCTGCGCGATTGATTATCAAACCcatatgaata
tcctccttagt-3=. The primers used for both amplifying the galK::cat deletion
for allelic exchange into E. coliNissle 1917 Strr envZP41L and sequencing to
confirm its presence in both E. coli Nissle 1917 Strr galK::cat and E. coli
Nissle 1917 Strr envZP41L galK::cat were as follows: primer 1 (43 bp
upstream of the galK coding sequence), 5=-AACAGGCAGCAGAGCGTT
TGC-3=; and primer 2 (53 bp downstream of the galK coding sequence),
5=-AGTCCATCAGCGTGACTACCATC-3=. The same primers were used
for replacement of the galK::cat mutation in E. coli Nissle 1917 Strr
envZP41L galK::cat with the wild-type galK gene and for confirmation of
the replacement by sequencing.
Replacing the E. coli MG1655 envZ gene with the E. coli Nissle 1917
envZ gene was done in two steps. First, to replace the E. coliMG1655 envZ
gene with the cassette encoding kanamycin resistance (kan) andwith parE
under the control of the rhamnose promoter (kan-rhaP-parE) (3), the
following primers were used on pKD267 DNA (uppercase letters, E. coli
MG1655 DNA; lowercase letters, kan-rhaP-parE DNA): primer 1, 5=-GT
ATCTTATAGAAAGCAAAACGGGAGGCACCTTCGCCTCCCGTTTA
TTTACCCTCTTTTGTCtcccgctcagaagaactcgt-3=; and primer 2, 5=-GC
TTCTCGCCACGAAGTTCATTTGCCCGTACGTTATTGCTCAT
CGTCACCTTGCTGTTCGggatccaatcagcccttgag-3=. Second, to replace
the kan-rhaP-parE cassette in E. coli MG1655 with the E. coli Nissle 1917
envZ gene, the following primers were used on E. coli Nissle 1917 DNA
(uppercase letters, sequence common to E. coliMG1655 and E. coliNissle
1917; lowercase letters, sequence found only in E. coliMG1655): primer 1,
5=-tatctatccagtatcttatagaaagcAAAACGGGAGGCACCTTCGCCT
CCCGTTTATTTACCCTTCTTTTGTC-3=; and primer 2, 5=-TCTAAAG
CATGAGGCGATTGCGCTTCTCGCCACGAAGT-3=.
Replacing the E. coli Nissle envZ gene with the envZP41L gene was also
done in two steps. First, to replace the E. coli Nissle 1917 envZ gene with
the cassette encoding kanamycin resistance (kan) and parE under the
control of the rhamnose promoter (kan-rhaP-parE), the following prim-
ers were used on pKD267 DNA (uppercase letters, E. coli Nissle 1917
DNA; lowercase letters, kan-rhaP-parE DNA): primer 1, 5=-TTCATTAT
CAATCAATTGAAAACAATCTAAAAACGGGAGGCACCTTCACC
TCCCGTTTTTTTACCCTTCTTTTGTCtcccgctcagaagaactcgtc-3=; and
primer 2, 5=-GCTTCTCGCCACGAAGTTCATTTGCCCGTACGTTATT
GCTCATCGTCACCTTGCTGTTCGggatccaatcagcccttgag-3=. Second, to
replace the kan-rhaP-parE cassette in E. coliNissle 1917 with the envZP41L
gene, the following primers were used on E. coli MG1655 envZP41L DNA:
primer 1 (uppercase letters, E. coli Nissle 1917 DNA sequence; lowercase
letters, envZP41L sequence), 5=-CTTTTGCAAGCGAATCCTT
TCATTATCAATCAATTGAAAACAATCTAAAAACGGGAGGCACCT
TCACCTCCCGTTTTTttacccttcttttgtcgtgc-3=; and primer 2 (sequence
common to both E. coli MG155 and E. coli Nissle 1917), 5=-TCGACGTG
CAGATTTCGCGT-3=. The primers used for confirmation of the envZ
replacements by sequencing were as follows: primer 1, 5=-GTAGCGGCT
GGTCCGAA-3=; and primer 2, 5=-TAGCTGGTGACGAACGTGAG-3=.
Colicin V sensitivity. E. coli F-18 produces colicin V (31). E. coli
MG1655 strains to be tested for sensitivity to colicin V were grown over-
night in LB broth Lennox at 37°C with shaking in 125-ml tissue culture
bottles. The next day, 106CFUof each strain to be testedwas added to 3ml
of Luria broth Lennox containing 7 g/liter Difco agar (soft agar), which
was thenpoured onto a 20-ml Luria broth Lennox agar plate. After the soft
agar on each plate solidified, E. coli F-18 colonies were transferred by
toothpick to each plate and incubated for 18 h at 37°C, and zones of
growth inhibition were measured.
FISH. Fluorescence in situ hybridization (FISH) was performed as
described previously (3, 32). Briefly, the cecum of a mouse designated for
FISH was cut into 1- to 2-cm pieces, suspended in Tissue-Tek OCT com-
pound (Sakura, Torrance, CA), and snap-frozen in 2-methylbutane sus-
pended in liquid nitrogen. Pieces were then stored at 80°C until ready
for sectioning. For sectioning, an UltraPro 5000 cryostat (Vibratome, St.
Louis, MO) was used to cut 10-m sections, which were adhered to poly-
L-lysine-treated slides for visualization. Slides were fixed in 4% parafor-
maldehyde for 1 h at room temperature, followed by awash in phosphate-
buffered saline for 10min. Slideswere allowed to air dry overnight prior to
hybridization. Fluorescent probes were diluted in hybridization solution
(0.1 M Tris-HCl buffer, pH 7.2, 0.9 M NaCl, and 0.1% SDS). The E. coli
23S rRNA-specific Cy-3 probe (5=-5Cy3-CAC CGT AGTGCC TCG TCA
TCA-3=) (red) and the eubacterial 23S rRNA-specific FitC probe (5=-GCT
GCC TCC CGT AGG AGT-36-FAM-3=) (green) were used at concentra-
tions of 5 ng/l and 25 ng/l, respectively. Subsequently, 10 l of diluted
probes in hybridization solution was pipetted onto each slide. Each slide
was then coveredwith aHybriSlip hybridization cover (Life Technologies,
Carlsbad, CA) and allowed to incubate in the dark for 2 h at 50°C. The
slides were then placed in a wash buffer (0.1 M Tris-HCl buffer, pH 7.2,
and 0.9MNaCl) and allowed to soak for 20 min at 50°C. Slides were then
rinsed with distilled water and air dried overnight. Sections were viewed
by confocal microscopy. Prior to viewing, sections on the poly-L-lysine-
treated slides were treated with Vectashield mounting medium (Vector
Laboratories, Burlingame, CA), an antibleaching agent which helps to
prolong fluorescence for imaging, and covered with a coverslip.
Statistics.Means and standard deviations derived from the indicated
numbers of samples in Tables 2 and 3 were compared by two-tailed Stu-
dent’s t test (P values). The colonization data on E. coli Nissle 1917
envZP41L between days 3 and 15 in Fig. 5Awere combined, as were those of
E. coli Nissle 1917, and the means for the two strains were compared by
two-tailed Student’s t test (see Fig. 5A). The same analysis was applied to
E. coliNissle 1917 envZP41L restored to the wild type with respect to envZ,
as well as E. coli Nissle 1917 (see Fig. 5B). P values of 	0.05 were inter-
preted as indicating no significant difference, and P values of
0.05 were
interpreted as indicating a significant difference.
RESULTS
The E. coli Nissle 1917 envZ gene bestows no colonization ad-
vantage to E. coli MG1655. The E. coli Nissle 1917 EnvZ protein
differs from that of E. coli MG1655 in two places: the V25A and
M446T changes. Since E. coliNissle 1917 is a probiotic strain con-
sidered to have enhanced colonization properties, it was possible
that the E. coli Nissle 1917 envZ gene (called envZNis here) might
confer increased colonization ability to E. coli MG1655. To test
this possibility, the E. coli MG1655 envZ gene was replaced with
envZNis to create E. coli MG1655 envZNis, and the colonization
ability of this strain was examined. E. coli MG1655 and E. coli
MG1655 envZNis were found to be identical in colonization ability,
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i.e., when 105 CFU of each strain was fed to mice, the strains
cocolonized equally well (Fig. 1A); when 1010 CFU of E. coli
MG1655 envZNis and 10
5 CFU of E. coliMG1655 were fed tomice,
the 105 ratio of the input CFU values of the 2 strains in feces was
maintained throughout the 15-day duration of the experiment
(Fig. 1B); andwhen 1010 CFUof E. coliMG1655 and 105 CFUof E.
coli MG1655 envZNis were fed to mice, the 10
5 ratio of the input
CFUvalues of the 2 strainswasmaintained in feces throughout the
15-day duration of the experiment (Fig. 1C). Therefore, despite
the two amino acid differences between the wild-type envZ genes
of E. coli Nissle 1917 and E. coli MG1655, the E. coli Nissle 1917
envZ gene conferred no colonization advantage to E. coliMG1655.
Effects of envZ missense mutations on OmpF, OmpC, and
phosphorylated OmpR (OmpRP) in E. coli MG1655 and E.
coliNissle 1917.The phenotypic effects of the P41Lmissensemu-
tation in the E. coli MG1655 envZ gene (envZP41L) reported previ-
ously were consistent with it containing a higher level of Om-
pRP than that in E. coli MG1655 (3). In order to test this
possibility, we examined OmpRP levels in these strains. At low
osmolality, the wild-type E. coli MG1655 strain had no detectable
OmpRP, and at high osmolality, the OmpRP level in the wild-
type strain was barely detectable (Fig. 2A). In contrast, E. coli
MG1655 envZP41L exhibited an extremely high level of OmpRP
at low osmolality that did not appear to increase further at high
osmolality (Fig. 2A). P148S and V33E mutants behaved similarly
(Fig. 2A).
The elevated levels of OmpRP observed in the E. coli
MG1655 envZ mutant strains even at low osmolality (Fig. 2A)
suggested that OmpC levels should also be elevated (10). We pre-
pared outer membranes and examined the porin content of cells
grown at low and high osmolalities (Fig. 2B). As expected (10), in
the wild-type strain, OmpF was the major porin at low osmolalityFIG 1 Colonization of the mouse intestine by E. coli MG1655 and E. coli
MG1655 envZNis. (A) Two sets of three mice were fed 10
5 CFU of E. coli
MG1655 Strr Nalr envZNis () and 10
5 CFU of E. coli MG1655 Strr (Œ). (B)
Two sets of three mice were fed 1010 CFU of E. coli MG1655 Strr envZNis ()
and105 CFU of E. coli MG1655 Strr Nalr (Œ). (C) Two sets of three mice were
fed 1010 CFU of E. coli MG1655 Strr (Œ) and 105 CFU of E. coli MG1655 Strr
envZNis (). At the indicated times, fecal samples were homogenized, diluted,
and plated as described in Materials and Methods. When necessary, i.e., to
distinguish strains, 100 colonies from plates containing streptomycin were
transferred by toothpick onto MacConkey agar plates containing streptomy-
cin and nalidixic acid. Error bars represent standard errors of the log10 mean
CFU per gram of feces.
FIG 2 (A) OmpRP levels in E. coli MG1655 (wt), the MG1655 envZ mis-
sense mutants, and MG1655 envZP41L restored to the wild type, grown in the
absence (low osmolality) or presence (high osmolality) of 15% sucrose. (B)
OmpCandOmpF in the outermembranes of theE. coliMG1655 strains grown
in the absence () or presence () of 15% sucrose. Sizes of prestainedmolec-
ular standards are indicated on the left.
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(Fig. 2B), and OmpC was the major porin at high osmolality (Fig.
2B). In the P41L background, OmpC was present at low osmola-
lity, andOmpFwas completely absent (Fig. 2B).OmpF expression
was normal in the P41L strain restored to the wild type (Fig. 2B).
The P148S andV33Emutants behaved similarly to the P41L strain
(Fig. 2B). Thus, the E. coli MG1655 envZ missense mutants ex-
press OmpC at low osmolality and repress OmpF, consistent with
the elevated OmpRP levels shown in Fig. 2A (10).
We were next interested in determining whether envZP41L
would have the same effect on E. coli Nissle 1917 and therefore
replaced theE. coliNissle 1917 envZ genewith envZP41L to createE.
coli Nissle 1917 envZP41L. Indeed, envZP41L had the same effect in
E. coli Nissle 1917 envZP41L as in E. coli MG1655 envZP41L, i.e.,
under conditions of low osmolality, E. coli Nissle 1917 envZP41L
contained a much higher level of OmpRP than E. coli Nissle
1917 (Fig. 3A) and, as a result, a higher level of OmpC and a far
lower level of OmpF in its outer membrane (Fig. 3B).
Effects of envZP41L on E. coliNissle 1917 motility, sensitivity
to bile salts and colicin V, and growth rate on galactose. The
mutant envZP41L gene in E. coli MG1655 envZP41L causes it to be
less motile than E. coli MG1655, because the higher level of
OmpRP negatively regulates production of FlhD4C2, themaster
regulator of flagellum biosynthesis (12). E. coli MG1655 envZP41L
is more resistant to bile salts than E. coli MG1655 and E. coli
MG1655flhD, because higher levels of OmpRP negatively reg-
ulate production of OmpF, the porin that transports bile salts (33)
(Fig. 2B). A higher level of OmpRP also causes E. coli MG1655
envZP41L to bemore resistant to colicin V than E. coliMG1655 and
E. coli MG1655 flhD, because OmpRP positively regulates the
transcription of omrA and omrB, which encode two small RNAs
that negatively regulate the expression of a number of outermem-
brane proteins, including CirA, the receptor for colicin V (13).
Finally, for as yet unknown reasons, the envZP41L gene causes E.
coli MG1655 envZP41L to grow 30% faster on galactose as the sole
carbon and energy source thanE. coliMG1655 andE. coliMG1655
flhD (3). We were interested in determining whether envZP41L
would have the same effect on E. coliNissle 1917, and therefore E.
coli Nissle 1917 envZP41L and E. coli Nissle 1917 were tested for
motility, resistance to bile salts, resistance to colicin V, and growth
rate on galactose. Indeed, E. coli Nissle 1917 envZP41L was less
motile (Table 2), more resistant to colicin V (Table 2), and more
resistant to bile salts than E. coli Nissle 1917 (Fig. 4). However, E.
coliNissle 1917 envZP41L grew about 15% slower than E. coliNissle
1917 on galactose (Table 3). Still, three of the four phenotypic
characteristics ascribed to the envZP41L gene were transferred to E.
coliNissle 1917. The hypothesis that the phenotypic changes in E.
coli Nissle 1917 envZP41L were due to the envZP41L gene was sup-
FIG 3 (A) OmpRP levels in E. coli Nissle 1917 (wt), Nissle 1917 envZP41L,
and Nissle 1917 envZP41L restored to the wild type. Bacteria were grown in
glucose M9 minimal medium modified by addition of 150 mM NaCl to ap-
proximate the sodium chloride concentration in intestinal fluids. (B) OmpC
and OmpF in the outer membranes of the E. coli Nissle 1917 strains grown in
the absence (; low osmolality) or presence (; high osmolality) of 15%
sucrose. Sizes of prestained molecular standards are indicated on the left.
TABLE 2Motility and colicin V sensitivity of E. coli Nissle 1917 strains
Strain
Colicin V sensitivity
(mean zone of
inhibition [mm]
SD) (n 12)a
Mean motility spread
(mm) SD (n 6)a
E. coli Nissle 1917 2.06 0.47 1.08 0.31
E. coli Nissle 1917 envZP41L 0.44 0.37* 0.60 0.20***
E. coli Nissle 1917 restored
to wild type with respect
to EnvZ
2.41 0.24** 1.02 0.15**
a Spread of E. coli Nissle 1917 strains on Luria motility agar containing 200 mM NaCl
after 6 h at 37°C or zones of inhibition of growth of the strains caused by colicin V
produced by E. coli F-18 overnight at 37°C, as described in Materials and Methods.
Student’s t test P values were calculated for each strain relative to E. coli Nissle 1917 in
the same experiment. *, P
 0.00001; **, P	 0.10; ***, P
 0.01.
FIG 4 Growth of E. coli Nissle 1917 strains in the presence of 5% bile salts. E.
coliNissle 1917 Strr (Œ), E. coliNissle 1917 Strr envZP41L (), and E. coliNissle
1917 Strr envZP41L restored to the wild type with respect to envZ (o) were
grown in Luria broth Lennox containing 5% (wt/vol) bile salts. Incubationwas
done at 37°C with aeration. The means and standard deviations of the A600
values at the indicated times are presented for three independent cultures of
each strain. In Student’s t tests on each time point between 3.5 h and 6.5 h for
E. coliNissle 1917 Strr envZP41L versus E. coliNissle 1917 Str
r and E. coliNissle
1917 Strr envZP41L versus E. coli Nissle 1917 Str
r envZP41L restored to the wild
type with respect to envZ, P
 3 104. In Student’s t tests on each time point
between 3.5 h and 6.5 h for E. coliNissle 1917 Strr versus E. coliNissle 1917 Strr
envZP41L restored to the wild type with respect to envZ, P	 0.80.
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ported by the fact thatwhen the envZP41L gene inE. coliNissle 1917
envZP41L was replaced with the wild-type E. coli Nissle 1917 envZ
gene, the restored E. coliNissle 1917 strainwasmoremotile (Table
2), more sensitive to colicin V (Table 2), andmore sensitive to bile
salts (Fig. 4), and grew faster on galactose, than E. coliNissle 1917
envZP41L (not shown).
Growth of E. coli Nissle 1917 envZP41L on a variety of sugars
present in mucus in vitro. We previously reported that E. coli
MG1655 envZP41L grew slower than E. coli MG1655 flhD on ar-
abinose, fucose, glucose, maltose, and mannose, at the same rate
as E. coli MG1655 flhD on fructose, gluconate, and ribose, and
faster than E. coliMG1655flhD on galactose andN-acetylgluco-
samine (3). In contrast, E. coli Nissle 1917 envZP41L did not grow
faster than E. coliNissle 1917 on any of the sugars tested and grew
slower than E. coli Nissle 1917 on a number of sugars, i.e., with
doubling times about 15% greater than that of E. coli Nissle 1917
on galactose, 10% greater on gluconate, 40% greater on maltose,
and 30% greater on mannose (Table 3). Apparently, the effect of
envZP41L on sugar metabolism is strain specific. Of the sugars
tested, E. coliNissle 1917 is known to use arabinose, fucose, galac-
tose, gluconate, and mannose to colonize the streptomycin-
treated mouse large intestine (34).
Growth of E. coli Nissle 1917 envZP41L in cecal mucus in
vitro. E. coli colonizes the intestine by growing in intestinal mucus
(35, 36), which contains at least 13 different sugars that can be
used by E. coli as sole sources of carbon.When E. coliMG1655 and
E. coliNissle 1917 colonize the streptomycin-treatedmouse intes-
tine, they simultaneouslymetabolize a number of these sugars (37,
38). Colonization requires bacteria to penetrate the mucus layer,
compete for nutrients with the microbiota, and divide at a rate
that is at least equal to the washout rate caused by sloughing of the
mucus layer into feces (35, 36). We previously reported that de-
spite being as good an intestinal colonizer, E. coli MG1655
envZP41L grew 15% slower than E. coli MG1655 flhD in mouse
cecal mucus in vitro (3). Even more dramatically, the doubling
time of E. coli Nissle 1917 envZP41L was twice that of E. coli Nissle
1917 in mouse cecal mucus in standing cultures in vitro (Table 3),
i.e., it grew far slower than E. coli Nissle 1917 (P
 0.001).
E. coliNissle 1917 envZP41L is a better mouse intestinal colo-
nizer than E. coli Nissle 1917. Since E. coli Nissle 1917 envZP41L
grew slower than E. coli Nissle on a number of sugars present in
cecalmucus and in cecalmucus itself in vitro, it would be expected
that if colonizing ability was based solely on the ability of a strain
to utilize sugars present in mucus for growth, E. coli Nissle
envZP41L would be the poorer colonizer. Yet E. coli Nissle 1917
envZP41Lwas about a 10-fold better colonizer thanwild-typeE. coli
Nissle 1917 when 105 CFU of each strain was fed to mice (P 
3.49 107) (Fig. 5A). The hypothesis that the better colonizing
ability of E. coliNissle 1917 envZP41L was due to the envZP41L gene
was supported by the fact that when the envZP41L gene in E. coli
Nissle 1917 envZP41L was replaced with the wild-type E. coliNissle
1917 envZ gene, the restored E. coli Nissle 1917 and wild-type E.
coliNissle 1917 strains had identical colonizing abilities (P 0.16)
(Fig. 5B).
We found previously that despite E. coli MG1655 envZP41L
growing about 15% slower than E. coli MG1655 flhD in mouse
cecal mucus in vitro, large numbers of E. coli MG1655 envZP41L
(1010 CFU) prevented small numbers of E. coli MG1655 flhD
(105CFU) fromgrowing to larger numbers in themouse intestine,
whereas small numbers of E. coli MG1655 envZP41L were able to
grow to larger numbers in the presence of large numbers of E. coli
MG1655 flhD (3). Similarly, despite E. coli Nissle 1917 envZP41L
growing far slower than E. coli Nissle 1917 in mouse cecal mucus
in vitro and on a number of sugars present in mucus, large num-
bers of E. coliNissle 1917 envZP41L prevented small numbers of E.
coli Nissle 1917 from growing to larger numbers in the mouse
intestine (Fig. 5C), suggesting that E. coli Nissle 1917 envZP41L
resides in and competes effectively in all intestinal niches occupied
by E. coli Nissle 1917. In contrast, despite its growing 50% slower
than E. coliNissle 1917 in mouse cecal mucus in vitro, small num-
bers of E. coli Nissle 1917 envZP41L grew to larger numbers in the
presence of large numbers of E. coliNissle 1917 (Fig. 5D), suggest-
ing that E. coliNissle 1917 envZP41L resides in at least one intestinal
niche that E. coli Nissle 1917 fails to colonize or colonizes poorly.
Moreover, the growth of E. coliNissle 1917 envZP41L from small to
large numbers in the presence of large numbers of E. coli Nissle
1917was not restricted to themucus layer of any one section of the
intestine, i.e., it did so in ileal mucus, cecal mucus, and colonic
mucus in vivo (Table 4).
E. coliNissle 1917 envZP41L uses galactose to grow fromsmall
to large numbers in vivo in the presence of large numbers of E.
coli Nissle 1917. Previously we showed that E. coli MG1655
envZP41L, which grows 30% faster than E. coli MG1655 on galac-
tose, uses galactose to grow from small to large numbers in the
mouse intestine in the presence of large numbers of E. coli
MG1655flhD (3). Here we show that E. coliNissle 1917 envZP41L
also uses galactose to grow from small to large numbers in the
mouse intestine in the presence of large numbers of E. coli Nissle
1917, despite growing 15% slower than E. coli Nissle 1917 in vitro
on galactose (Table 3). That is, small numbers ofE. coliNissle 1917
envZP41LgalK failed to grow to larger numbers in the presence of
large numbers of E. coliNissle 1917 (Fig. 6A), whereas small num-
bers of E. coli Nissle 1917 galK restored to the wild type with
respect to galactose utilization did so (Fig. 6B). These data suggest
that E. coli Nissle 1917 envZP41L uses galactose to colonize an in-
TABLE 3 Generation times of E. coli Nissle 1917 and E. coli Nissle 1917
envZP41L on various sugars
a
Carbon sourceb
Mean generation time (min) SD (n 3)
E. coli Nissle 1917
E. coli Nissle 1917
envZP41L
c
Arabinose 66 1 64 1*
Fructose 96 4 99 1**
Fucose 83 1 79 4**
Galactose 69 1 81 4***
Gluconate 61 2 67 1***
Glucose 89 2 92 2**
Maltose 85 3 120 2****
Mannose 129 7 164 7†
N-Acetylglucosamine 84 1 83 1**
Ribose 104 7 108 8**
Cecal mucus 52 3 100 3****
a Generation times were calculated from semilogarithmic plots.
b Carbon source utilization was determined in M9 minimal medium (0.4% [wt/vol]) in
125-ml tissue culture flasks with shaking after inocula were grown on M9 glycerol
(0.4% [vol/vol]) and then overnight on the specified carbon source.
c Each P value refers to a comparison between the generation times of E. coli Nissle 1917
and E. coli Nissle 1917 envZP41L growing on a specific sugar: *, P	 0.05; **, P	 0.10;
***, P
 0.05; ****, P
 0.001; †, P 0.0036.
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testinal niche that E. coli Nissle 1917 fails to colonize or colonizes
poorly.
E. coliNissle 1917 resides closely associatedwith othermem-
bers of the microbiota in the mouse intestine. Since commensal
E. coli strains colonize the streptomycin-treated mouse intestine
by growing in the intestinal mucus layer of the large intestine (35,
36), and since it has been shown that E. coli MG1655 resides in
mixed biofilms in the mouse cecal mucus layer (3), we examined
whether E. coliNissle 1917 also resides inmixed biofilms inmucus
in vivo. Indeed, as shown in Fig. 7A, E. coli Nissle 1917 appears to
reside in the cecalmucus layer, closely associatedwith othermem-
bers of the microbiota. As expected, E. coli was not found in the
cecal mucus of mice not fed E. coli Nissle 1917 (Fig. 7B).
Protection against E. coli EDL933 colonization by E. coli
Nissle 1917 and E. coli Nissle 1917 envZP41L. Different resident
commensal E. coli strains vary by as much as 10,000-fold with
respect to the level of colonization of the prototypic enterohem-
orrhagic E. coli strain EDL933 that they allow in the streptomycin-
treated mouse intestine (38). Among several commensal strains
previously tested, E. coliNissle 1917 was one of the best at limiting
E. coli EDL933 colonization, i.e., in mice precolonized with E. coli
Nissle 1917 and then fed 105 CFU of E. coli EDL933 10 days later,
E. coli EDL933 dropped from 105 CFU/g of feces and colonized at
a level between 103 and 104 CFU/g of feces (39).While this level of
colonization is low, as long as the relatively fewE. coliEDL933 cells
are healthy and able to persist in the intestine at that low level, they
might also be able to initiate the pathogenic process in humans by
damaging the mucosa, resulting in subsequent disease. It was
therefore of interest to determine whether E. coli Nissle 1917
FIG 5 Colonization of the mouse intestine by E. coliNissle 1917, E. coliNissle 1917 envZP41L, and E. coliNissle envZP41L restored to the wild type. (A) Three sets
of three mice were fed 105 CFU of E. coli Nissle 1917 Strr Nalr (Œ) and 105 CFU of E. coli Nissle 1917 Strr envZP41L (). (B) Two sets of three mice were fed 10
5
CFU of E. coliNissle 1917 Strr Nalr (Œ) and 105 CFU of E. coliNissle Strr envZP41L restored to the wild type (). (C) Two sets of three mice were fed 10
5 CFU of
E. coli Nissle 1917 Strr Nalr (Œ) and 1010 CFU of E. coli Nissle 1917 Strr envZP41L (). (D) Six sets of three mice were fed 10
5 CFU of E. coli Nissle 1917 Strr (Œ)
and 105 CFU of E. coliNissle 1917 Strr Nalr envZP41L (). At the indicated times, fecal samples were homogenized, diluted, and plated as described in Materials
andMethods.When necessary, i.e., to distinguish strains, 100 colonies from plates containing streptomycin were transferred by toothpick ontoMacConkey agar
plates containing streptomycin and nalidixic acid. Error bars represent standard errors of the log10 mean CFU per gram of feces.
TABLE 4 E. coli Nissle 1917 and E. coli Nissle 1917 envZP41L
populations in mouse ileal, cecal, and colonic mucus at 15 days
postfeeding
Location
Log10 CFU
a
Log10 ratio of Nissle
1917 to Nissle 1917
envZP41LNissle 1917
Nissle 1917
envZP41L
Ileal mucus 5.01 0.71 3.18 0.57 1.83
Cecal mucus 7.51 0.24 6.30 0.15 1.21
Colonic mucus 6.96 0.33 5.71 0.21 1.25
Feces 8.88 0.07 7.82 0.38 1.06
a Mice were fed 1010 CFU of E. coli Nissle 1917 and 105 CFU of E. coli Nissle 1917
envZP41L as described in the legend to Fig. 4D, and the animals were sacrificed on day
15. The values are means standard errors of the means for three mice. Mucus
preparations were isolated on day 15 postfeeding. The CFU values for the mucus
preparations were corrected for the entire volume of each mucus preparation. The fecal
values are numbers of CFU/g of feces 15 days after feeding.
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envZP41L, the better colonizer, was better than E. coliNissle 1917 at
limiting E. coli EDL933 colonization. It was not. In fact, although
not statistically significant, it appeared that E. coli Nissle 1917
envZP41L was not quite as effective as E. coliNissle 1917 in limiting
E. coli EDL933 growth in the intestine (compare Fig. 8A and B).
DISCUSSION
When a bacterial species persists indefinitely in stable numbers in
the intestine of an animal, without repeated introduction, the an-
imal is, by definition, colonized by the bacterium. Commensal E.
coli strains colonize the human intestine in the presence of a dense
and diverse intestinal microbiota comprised of at least 500 culti-
vable species and 1013 to 1014 total bacteria (40). Unfortunately, E.
coli colonization cannot be studied experimentally in conven-
tional animals due to colonization resistance, which results when
all niches are filled by the microbiota (41). Such experiments re-
quire an animal model with open niches for E. coli to colonize in
relatively large numbers, but the animal model intestine should
have a dense and diverse anaerobic community that matches as
closely as possible the native microbiota of the conventional ani-
mal in order to examine interactions among members of the mi-
crobiota. The streptomycin-treated mouse model is used rou-
tinely for this purpose because it fulfills these criteria (35, 36).
FIG 6 Colonization of the mouse intestine by E. coli Nissle 1917 envZP41L, E.
coliNissle 1917 envZP41LgalK, andE. coliNissle 1917 envZP41LgalK restored
to the wild type. (A) Three sets of threemice were fed 1010 CFU of E. coliNissle
1917 Strr (Œ) and 105 CFU of E. coli Nissle 1917 Strr galK::cat (). (B) Two
sets of threemice were fed 1010 CFU of E. coliNissle 1917 Strr (Œ) and 105 CFU
of E. coli Nissle 1917 Strr Nalr galK::cat restored to the wild type (). At the
indicated times, fecal samples were homogenized, diluted, and plated as de-
scribed in Materials and Methods. Error bars represent standard errors of the
log10 mean CFU per gram of feces.
FIG 7 In situ hybridization with fluorescence-labeled oligonucleotide probes.
Ten days after feeding mice E. coli Nissle 1917 Strr (A) and 5 days after sham
feeding mice without E. coli (B), cecal mucosal sections were hybridized with
an E. coli-specific oligonucleotide probe (red) and a eubacterium-specific oli-
gonucleotide probe (green). EP, epithelium. E. coli cells appear red, while all
other bacteria appear green.
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This study was undertaken to determine whether the envZP41L
gene, selected in E. coli MG1655 by the streptomycin-treated
mouse intestine (3), wouldmake the probiotic strain E. coliNissle
1917 a better mouse intestine colonizer and better able to resist
colonization by E. coli EDL933, an enterohemorrhagic strain. The
data presented here clearly show that despite being a 10-fold better
colonizer than E. coli Nissle 1917 and despite appearing to colo-
nize an intestinal niche not colonized by E. coliNissle 1917, E. coli
Nissle 1917 envZP41L is not better than E. coliNissle 1917 at limit-
ing E. coli EDL933 growth in the intestine (Fig. 8).
The concept that nutrient availability dictates the community
structure of the intestine was originally presented in Freter’s nu-
trient-niche hypothesis, which states that species coexist in the
intestine because each is able to grow faster than all others on one
or a few limiting nutrients and that the rate of growth of each
species during the colonization process is at least equal to its wash-
out rate from the intestine (42). The hypothesis assumes that all
nutrients are perfectly mixed and that they are equally available to
all species present in the intestine. According to the hypothesis,
two strains cannot coexist in the intestine when one competes less
well than the other for the same nutrient(s), unless the metaboli-
cally less efficient one adheres to the intestinal wall (42). As a
corollary to the hypothesis, when two strains each use one ormore
major nutrients better than the other strain, small numbers of
each strain will grow up in the intestine to larger numbers in the
presence of large numbers of the other strain, as observed in
mouse colonization studies using a number of human fecal E. coli
strains isolated from different humans (39).
Despite general acceptance of the nutrient-niche hypothesis,
recent data suggest that it is not entirely correct for E. coli (3). We
recently reported that E. coli MG1655 envZP41L, selected by the
mouse intestine as a better colonizer than E. coli MG1655, colo-
nizes as well as E. coli MG1655 flhD, also a better colonizer se-
lected by the mouse intestine, but grows less well than E. coli
MG1655 flhD in bacterium-free mouse cecal mucus in vitro and
on several sugars present in cecal mucus (3). These results were in
contrast to what would be expected if the nutrient-niche hypoth-
esis were entirely correct as discussed above. Furthermore, E. coli
requires mono- and disaccharides for growth in the intestine (35,
36), but mono- and disaccharides present in the diet are unlikely
to be available to E. coli because they are absorbed in the small
intestine. The anaerobes in the intestine secrete polysaccharide
hydrolases (43), but E. coli cannot do so (44, 45). Indeed, Salmo-
nella enterica serovar Typhimurium,which is in the same family as
E. coli and has a very similar metabolism, catabolizes fucose and
sialic acid liberated from mucosal polysaccharides by Bacteroides
thetaiotaomicron (46). It therefore is clear that E. coli obtains the
bulk of the mono- and disaccharides it requires for growth in the
intestine from degradation of dietary fiber-derived and mucin-
derived polysaccharides by anaerobes. In view of this information
and since we found that E. coliMG1655 resides in mixed biofilms
in themucus layer of the intestine but does not appear to adhere to
the intestinal wall, to explain our findings we suggested the “res-
taurant hypothesis” as a modification to the nutrient-niche hy-
pothesis (3). According to the restaurant hypothesis, the mono-
and disaccharides that E. coli requires for growth are not derived
from the diet and are not perfectly mixed in the intestine but are
served locally to E. coli by the anaerobes within themixed biofilms
that E. coli inhabits. The restaurant hypothesis also raises the pos-
sibility that E. coli strains with different surfaces (e.g., fimbriae,
capsule, O, K, and H antigens, outer membrane protein profiles,
etc.) might reside in mixed biofilms made up of different anaer-
obes that supply different sugars to those strains, which could
explain why different E. coli strains display different nutritional
programs in the intestine despite using the same sugars when cul-
tured in vitro (38, 39).
The data presented here are also consistent with the restaurant
hypothesis. E. coliNissle 1917 envZP41L did not grow faster than E.
coli Nissle 1917 on any of the sugars present in mucus that were
tested, grew 10% to 30% slower than E. coliNissle 1917 on several
of the sugars tested, and grew 50% slower in cecalmucus in vitro in
which all nutrients were perfectly mixed, i.e., in UV-sterilized ce-
cal mucus that had been centrifuged free of bacteria (Table 3). Yet
in contrast to what would be expected solely on the basis of com-
petition for nutrients fromamixture that is equally available to all,
E. coli Nissle 1917 envZP41L colonized the streptomycin-treated
mouse intestine 10-fold better in competition with E. coli Nissle
1917 (Fig. 5A) and grew from small to large numbers in themouse
intestine in the presence of large numbers of E. coli Nissle 1917
(Fig. 5D).
Although these data cannot be explained solely by the nutrient-
FIG 8 E. coli EDL933 colonization of the mouse intestine precolonized with
either E. coliNissle 1917 or E. coliNissle 1917 envZP41L. (A) Three sets of three
mice were fed 105 CFU of E. coli Nissle 1917 Strr Nalr (Œ) and, 10 days later,
were fed 105 CFU of E. coli EDL933 Strr Rifr (). (B) Three sets of three
micewere fed 105 CFUof E. coliNissle 1917 Strr Nalr envZP41L () and, 10 days
later, were fed 105 CFU of E. coli EDL933 Strr Rifr (). Data were collected and
plotted as described in the legend to Fig. 4.
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niche hypothesis, since E. coli Nissle 1917 strains appear to reside
in mixed biofilms in cecal mucus in vivo (Fig. 7A), the data can be
explained if the lower growth rate of E. coli Nissle 1917 envZP41L
than that of E. coli Nissle 1917 in those mixed biofilms is more
than compensated for by its ability to occupy most of the binding
sites in those biofilms, i.e., if E. coli Nissle 1917 envZP41L has a
greater affinity for biofilm binding sites than E. coliNissle 1917. If
so, then it is not surprising that when E. coli Nissle 1917 envZP41L
and wild-type E. coliNissle 1917 are fed tomice in equal numbers,
E. coli Nissle 1917 envZP41L is the better colonizer (Fig. 5A). Fur-
thermore, it is not surprising that when mice are fed E. coli Nissle
1917 envZP41L and wild-type E. coli Nissle 1917 at a ratio of 10
5:1,
the ratio reaches 106:1 with time (Fig. 5C). However, it is surpris-
ing that when mice are fed wild-type E. coliNissle 1917 and E. coli
Nissle 1917 envZP41L at a ratio of 10
5:1, E. coliNissle 1917 envZP41L
uses galactose to grow to larger numbers (Fig. 5D and 6A), despite
wild-type E. coli Nissle 1917 being able to grow faster than E. coli
Nissle 1917 envZP41L on galactose in vitro (Table 3). This can be
explained if E. coliNissle 1917 envZP41L uses galactose to grow in a
second niche that wild-type E. coli Nissle 1917 cannot colonize.
That second niche could be another mixed biofilm consisting of a
different group of anaerobes in which E. coliNissle 1917 envZP41L
has a higher affinity for binding sites than E. coli Nissle 1917 and
thereby prevents it from occupying that niche. Alternatively, that
second niche could be another mixed biofilm that contains an
anaerobe that makes a bacteriocin that inhibits wild-type E. coli
Nissle 1917 growth more than it inhibits E. coli Nissle 1917
envZP41L growth, much in the same way that E. coli Nissle 1917 is
more sensitive than wild-type E. coli Nissle 1917 to colicin V (Ta-
ble 2). To reiterate, we emphasize that the envZP41L mutation,
when transferred from E. coliMG1655 envZP41L into E. coliNissle
1917, directs E. coliNissle 1917 envZP41L to occupy a distinct niche
in which it is served galactose (Fig. 5D), just as it does in E. coli
MG1655 envZP41L (3). Moreover, occupation of the galactose
niche gives E. coli Nissle 1917 envZP41L a colonization advantage,
despite its growing more slowly on galactose than the wild type in
vitro. We consider this to be strong evidence for the restaurant
hypothesis.
In support of the view that surface differences between E. coli
Nissle 1917 envZP41L and E. coli Nissle 1917 could result in differ-
ent binding affinities for mixed biofilms, when we replaced the
envZNis gene in E. coliNissle 1917 with envZP41L, three phenotypic
changes observed in E. coli MG1655 envZP41L, caused by outer
membrane changes resulting from increased OmpRP, were
transferred to E. coli Nissle 1917 envZP41L. These surface changes,
i.e., decreased OmpF and increased OmpC (Fig. 3), decreased
CirA causing increased resistance to colicin V (3, 13) (Table 2),
and decreasedmotility (Table 2) caused by the negative regulatory
effect of increased OmpRP on the flhDC promoter (12), could
contribute to an increased affinity for binding sites in a mixed
biofilm. It has been shown that decreased motility favors biofilm
formation following the initial adhesion event (47) and that
OmpC can serve as an adhesin (48). It should also be mentioned
that increased OmpRP (Fig. 1) has been shown to stimulate
production of curli fibers that also stimulate biofilm formation
(49). It therefore seems reasonable thatE. coliNissle 1917 envZP41L
could have a higher affinity than E. coli Nissle 1917 for binding
sites on a mixed biofilm.
At this time, we do not know why despite being a better colo-
nizer than E. coli Nissle 1917, E. coli Nissle 1917 envZP41L is not
better at limiting E. coli EDL933 colonization than E. coli Nissle
1917; however, the possibility should be considered that when E.
coli EDL933 infects the mouse intestine, it initially grows plank-
tonically inmucus andnot inmixed biofilms. If we are correct that
E. coli Nissle 1917 and E. coli Nissle 1917 envZP41L colonize the
mouse intestine by being served specific sugars by the anaer-
obes in the mixed biofilms they inhabit, then small amounts of
these sugars that escape the mixed biofilms might be available
to invading E. coli EDL933 as well as to the small numbers of
planktonic E. coli Nissle 1917 or E. coli Nissle 1917 envZP41L that
leave the mixed biofilms. Therefore, it may be that both plank-
tonic E. coli Nissle 1917 envZP41L and E. coli Nissle 1917 compete
directly with planktonic E. coli EDL933 for the sugars that escape
the biofilms or that are produced by small numbers of planktonic
members of the rest of themicrobiota that leave the biofilms. This
scenario would allow planktonic E. coli EDL933 to colonize to the
extent allowed by the available concentrations of those sugars in
competition with planktonic E. coliNissle 1917 envZP41L or E. coli
Nissle 1917, which could explain why E. coliNissle 1917, the faster
grower in perfectly mixed mucus, appears to limit E. coli EDL933
growth in the intestinemore than E. coliNissle 1917 envZP41L does
(Fig. 8).
In summary, E. coli Nissle 1917 envZP41L is a 10-fold better
mouse intestinal colonizer than E. coli Nissle 1917, despite grow-
ing far slower than E. coli Nissle 1917 in bacterium-free, perfectly
mixed cecalmucus in vitro and on several sugars present inmucus,
yet it is not better at limiting E. coli EDL933 colonization. The data
presented here are consistent with the restaurant hypothesis for
commensalE. coli strains that colonize the intestine asmembers of
mixed biofilms and obtain the sugars they need for growth locally
(3). Indeed, introduction of an envZP41L mutation into either of
two E. coli commensal strains directs themutants to a niche that is
defined at least in part by the availability of galactose and cannot
be occupied by the parent strains. However, it may be that it is not
sessile E. coli but the small number of planktonic E. coli cells that
compete for sugars with invading E. coli pathogens. If so, then an
efficacious E. coli probiotic agent not only should be able to in-
habitmixed biofilms better than its parent and, as such, be a better
colonizer but also should be better at utilizing nutrients for
growth to outcompete the invading pathogen.
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